A citation-based method for searching scientific literature

Boris P Kovatchev. Nat Rev Endocrinol 2017
Times Cited: 89



Jingyi Lu, Xiaojing Ma, Jian Zhou, Lei Zhang, Yifei Mo, Lingwen Ying, Wei Lu, Wei Zhu, Yuqian Bao, Robert A Vigersky, Weiping Jia. Diabetes Care 2018
Times Cited: 124




List of shared articles



Times cited

The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.
Roy W Beck, Richard M Bergenstal, Peiyao Cheng, Craig Kollman, Anders L Carlson, Mary L Johnson, David Rodbard. J Diabetes Sci Technol 2019
87

Time in Range: How to Measure It, How to Report It, and Its Practical Application in Clinical Decision-Making.
Eugene E Wright, Kayla Morgan, Danny K Fu, Nick Wilkins, William J Guffey. Clin Diabetes 2020
0



Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study.
Jingyi Lu, Chunfang Wang, Yun Shen, Lei Chen, Lei Zhang, Jinghao Cai, Wei Lu, Wei Zhu, Gang Hu, Tian Xia,[...]. Diabetes Care 2021
5

Glycemic variability: adverse clinical outcomes and how to improve it?
Zheng Zhou, Bao Sun, Shiqiong Huang, Chunsheng Zhu, Meng Bian. Cardiovasc Diabetol 2020
8


A Review of Continuous Glucose Monitoring-Based Composite Metrics for Glycemic Control.
Michelle Nguyen, Julia Han, Elias K Spanakis, Boris P Kovatchev, David C Klonoff. Diabetes Technol Ther 2020
6

Glycemic variability and cardiovascular disease in patients with type 2 diabetes.
Marcela Martinez, Jimena Santamarina, Adrian Pavesi, Carla Musso, Guillermo E Umpierrez. BMJ Open Diabetes Res Care 2021
0

Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID Study.
Thomas Blevins, Wendy Lane, David Rodbard, Dana Sindelar, Ludi Fan, Kelly Ellinor, Liza Ilag, Trang Ly, Jennal Johnson. Diabetes Technol Ther 2021
1

Influence of glucometric 'dynamical' variables on duodenal-jejunal bypass liner (DJBL) anthropometric and metabolic outcomes.
Ana Col├ís, Manuel Varela, Milos Mraz, Daniel Novak, David Cuesta-Frau, Luis Vigil, Marek Benes, Terezie Pelikanova, Martin Haluzik, Vaclav Burda,[...]. Diabetes Metab Res Rev 2020
0

Estimation of Hemoglobin A1c from Continuous Glucose Monitoring Data in Individuals with Type 1 Diabetes: Is Time In Range All We Need?
Chiara Fabris, Lutz Heinemann, Roy Beck, Claudio Cobelli, Boris Kovatchev. Diabetes Technol Ther 2020
5

Log-linear relationship between endogenous insulin secretion and glycemic variability in patients with type 2 diabetes on continuous glucose monitoring.
Aika Miya, Akinobu Nakamura, Takahisa Handa, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, So Nagai, Yoichi M Ito, Hideaki Miyoshi, Tatsuya Atsumi. Sci Rep 2021
0

A View Beyond HbA1c: Role of Continuous Glucose Monitoring.
Haleh Chehregosha, Mohammad E Khamseh, Mojtaba Malek, Farhad Hosseinpanah, Faramarz Ismail-Beigi. Diabetes Ther 2019
28

Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study).
Gyuri Kim, Soo Lim, Hyuk-Sang Kwon, Ie B Park, Kyu J Ahn, Cheol-Young Park, Su K Kwon, Hye S Kim, Seok W Park, Sin G Kim,[...]. Diabetes Obes Metab 2020
4